Critical Care Medicine Doctors in Atlantis, FL Accepting Medicare

6 Critical Care Medicine doctors found. Showing 1 - 6

Denzil S Seedial, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave, Ste 204, Atlantis, FL 33462 Phone: 561-967-4118    Fax: 561-967-3463

Luis Javier Pena-hernandez, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave Ste 204, Atlantis, FL 33462 Phone: 561-967-4118

Belayet Hossain, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5401 S Congress Ave, # 204, Atlantis, FL 33462 Phone: 561-967-4118    Fax: 561-967-3463

Fares Qureiyeh, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5511 S Congress Ave, Suite 135, Atlantis, FL 33462 Phone: 561-642-3094    Fax: 561-642-3095

Dr. Syed Abbas Ali, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Jfk Dr Ste 134, Atlantis, FL 33462 Phone: 561-612-8080    Fax: 561-612-8084

Dr. Sri Kartik Anand Valluri, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-548-1273    Fax: 561-548-1572

News Archive

Roche announces FDA approval of new VENTANA PD-L1 assay

Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC).

Research shows how breakdowns in DNA copying process contribute to cancer

Research led by a scientist at the University of York has thrown new light on the way breakdowns in the DNA copying process inside cells can contribute to cancer and other diseases.

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Statins, a class of drugs used to lower cholesterol, are among the best selling drugs in North America and around the world. However, statin myopathy, which results in muscle pain and weakness, is a common side effect affecting up to 10 percent of statin users. A recent study led by Dr. Richard Kim of the Lawson Health Research Institute, in collaboration with Dr. Robert Hegele of Robarts Research Institute, and researchers from Vanderbilt University, found that commonly occurring genetic variations in a person's genes could put them at risk for statin-associated muscle injury.

Rate of chemotherapy administration for NSCLC more than twice that reported by SEER

For the first time to date, research published in the October edition of the Journal of Thoracic Oncology (JTO) sought to determine the use of chemotherapy in a contemporary, diverse non-small cell lung cancer (NSCLC) population encompassing all patient ages. Prior population-based studies have shown that only 20 to 30 percent of advanced lung cancer patients receive chemotherapy treatment.

New book provides roadmap to improve health of U.S. citizens

The U.S. is one of the wealthiest nations in the world but its citizens are far from the healthiest. In fact, the U.S. lags behind several other developed nations in life expectancy and other population health measures. These disparities persist despite the fact that the U.S. spends more money per capita than any other nation on healthcare delivery.

Read more Medical News

› Verified 6 days ago